title: Lymphomatoid granulomatosis induced by imatinib-treatment.
authors: Amir S
authors: AS
authors: Yazdi
authors: Gisela
authors: G
authors: Metzler
authors: Susanne
authors: S
authors: Weyrauch
authors: Mark
authors: M
authors: Berneburg
authors: Michael
authors: M
authors: Bitzer
authors: Hans-Konrad
authors: HK
authors: Müller-Hermelink
authors: Martin
authors: M
authors: Röcken
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008171:Lung Diseases / Q000139:chemically induced / Q000473:pathology; D008230:Lymphomatoid Granulomatosis / Q000139:chemically induced* / Q000473:pathology; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate